NPM-ALK regulated activation of the AP-1 transcription factor in anaplastic large cell lymphomas (ALCL)

被引：0
|
作者：
不详
机构：
来源：
PATHOLOGY RESEARCH AND PRACTICE | 2005年 / 201卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：223 / 224
页数：2
相关论文
共 50 条
  • [1] NPM-ALK regulated activation of the AP-1 transcription factor in anaplastic large cell lymphomas (ALCL)
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 150 - 151
  • [2] Variant NPM-ALK chimeric product in the anaplastic large cell lyphoma (ALCL).
    Zielenska, M
    Sirkin, WL
    Fabricius, N
    Zielenski, J
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A332 - A332
  • [3] Genes regulated by NPM-ALK fusion kinase play a key role in the activation of AP-1 transcription factors.
    Staber, PB
    Linkesch, W
    Schauer, S
    Moser, G
    Kadin, ME
    Dirks, W
    Hoefler, G
    BLOOD, 2004, 104 (11) : 74A - 74A
  • [4] Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas
    A Colomba
    D Courilleau
    D Ramel
    D D Billadeau
    E Espinos
    G Delsol
    B Payrastre
    F Gaits-Iacovoni
    Oncogene, 2008, 27 : 2728 - 2736
  • [5] Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas
    Colomba, A.
    Courilleau, D.
    Ramel, D.
    Billadeau, D. D.
    Espinos, E.
    Delsol, G.
    Payrastre, B.
    Gaits-Iacovoni, F.
    ONCOGENE, 2008, 27 (19) : 2728 - 2736
  • [6] The transcription factor CCAAT/enhancer binding protein (C/EBP)β is constitutively expressed in ALK-positive anaplastic large cell lymphomas (ALCL), and is dependent upon NPM-ALK kinase activity
    Quintanilla-Martinez, L
    Pittaluga, S
    Davies-Hill, T
    Miething, C
    Anastosov, N
    Rudelius, M
    Duyster, J
    Jaffe, ES
    Fend, F
    Raffeld, M
    MODERN PATHOLOGY, 2006, 19 : 242A - 242A
  • [7] The transcription factor CCAAT/enhancer binding protein (C/EBP)β is constitutively expressed in ALK-positive anaplastic large cell lymphomas (ALCL), and is dependent upon NPM-ALK kinase activity
    Quintanilla-Martinez, L
    Pittaluga, S
    Davies-Hill, T
    Miething, C
    Anastosov, N
    Rudelius, M
    Duyster, J
    Jaffe, ES
    Fend, F
    Raffeld, M
    LABORATORY INVESTIGATION, 2006, 86 : 242A - 242A
  • [8] Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas
    Drexler, HG
    Gignac, SM
    von Wasielewski, R
    Werner, M
    Dirks, WG
    LEUKEMIA, 2000, 14 (09) : 1533 - 1559
  • [9] IDENTIFICATION AND DIAGNOSTIC APPLICATION OF GENOMIC NPM-ALK FUSION SEQUENCES IN ANAPLASTIC LARGE CELL LYMPHOMAS
    Krumbholz, M.
    Damm-Welk, C.
    Woessmann, W.
    Metzler, M.
    HAEMATOLOGICA, 2017, 102 : 571 - 571
  • [10] Glycoproteomic signature of NPM-ALK (+) anaplastic large cell lymphoma
    Jeon, Y. K.
    Rolland, D.
    Basrur, V.
    Wolfe, T.
    Fermin, D.
    Elenitoba-Johnson, K. S.
    Lim, M. S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 : 32 - 32
12345